FRANK HACKL: Open Payments
NPI 1912030404 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 8 payments from 6 companies in 2025. Trend: 2023 $149 · 2024 $57 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Saluda Medical Americas, Inc. | 1 | $33 |
| UCB, Inc. | 1 | $23 |
| Valinor Pharma, LLC | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: Belbuca, RELISTOR, Evoke, Bimzelx, MOVANTIK, HORIZANT.
Industry payments across OK — which companies pay providers there.
